Ironwood Pharmaceuticals ... (IRWD)
NASDAQ: IRWD
· Real-Time Price · USD
1.07
0.00 (0.00%)
At close: Aug 15, 2025, 2:51 PM
Ironwood Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 308.52M | 317.68M | 351.41M | 378.42M | 400.56M | 413.55M | 442.74M | 432.38M | 427.28M | 417.13M | 410.6M | 420.53M | 415.64M | 422.44M | 413.75M | 413.3M | 413.02M | 398.43M |
Cost of Revenue | 109.25M | 109.29M | 109.32M | 31.36M | 2.04M | 1.8M | 1.57M | 1.4M | 1.26M | 12.44M | 12.51M | 12.53M | 23.07M | 23.78M | 38.91M | 39.45M | 50.24M | 60.15M |
Gross Profit | 277.75M | 286.86M | 320.56M | 347.06M | 398.53M | 411.75M | 441.16M | 430.98M | 426.02M | 404.69M | 398.09M | 408M | 392.56M | 398.65M | 374.84M | 373.85M | 362.79M | 338.28M |
Operating Income | 73.34M | 53M | 93.12M | 99.22M | 113.61M | -994.51M | -945.43M | -914.66M | -886.21M | 252.59M | 250.34M | 238.57M | 235.26M | 244.71M | 232.26M | 227.05M | 207.5M | 175.11M |
Interest Income | 3.62M | 4.17M | 4.47M | 4.88M | 5.48M | 12.87M | 18.97M | 23.22M | 24.28M | 16.54M | 9.5M | 4.24M | 1.61M | 760K | 726K | 766K | 819K | 923K |
Pretax Income | 42.91M | 23.97M | 65.2M | 71.56M | 86.13M | -1.01B | -948.07M | -906.16M | -868.19M | 261.82M | 252.42M | 226.41M | 216.18M | 216.76M | 200.66M | 198.9M | 175.04M | 145.87M |
Net Income | -7.88M | -32.34M | 880K | -2.46M | 9.21M | -1.05B | -1B | -952.28M | -917.29M | 181.98M | 175.06M | 167.57M | 173.1M | 527.32M | 528.45M | 530.28M | 508.86M | 142.76M |
Selling & General & Admin | 110.76M | 130.93M | 144.27M | 148.25M | 144.48M | 160M | 153.51M | 144.34M | 140.61M | 118.25M | 115.99M | 116.29M | 115.41M | 112.34M | 111.13M | 116.43M | 123.61M | 131.21M |
Research & Development | 106.02M | 113.04M | 111.42M | 121.09M | 124.25M | 1.22B | 1.21B | 1.18B | 1.16B | 46.29M | 44.27M | 65.67M | 65.03M | 65.74M | 70.41M | 54.82M | 65.61M | 75.52M |
Other Expenses | -117.56M | -115.02M | -131.53M | -53.12M | -47.71M | -35.64M | -10.27M | -10.27M | 14.13M | n/a | n/a | n/a | n/a | n/a | n/a | -3K | -3K | -3K |
Operating Expenses | 99.22M | 128.94M | 124.17M | 216.22M | 221.02M | 1.32B | 1.33B | 1.29B | 1.29B | 164.54M | 160.26M | 181.96M | 180.45M | 178.09M | 181.54M | 171.25M | 189.22M | 206.72M |
Interest Expense | 34.76M | 33.87M | 33.03M | 32.54M | 32.96M | 27.33M | 21.63M | 14.73M | 6.42M | 6.78M | 7.6M | 14.02M | 20.34M | 25.86M | 31.15M | 30.72M | 30.3M | 29.88M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 235.43M | 264.68M | 258.29M | 279.2M | 286.96M | 1.41B | 1.39B | 1.35B | 1.31B | 164.54M | 160.26M | 181.96M | 180.45M | 178.09M | 181.54M | 172.15M | 190.12M | 207.62M |
Income Tax Expense | 50.8M | 56.31M | 64.32M | 74.68M | 78.94M | 72.46M | 83.49M | 74.78M | 76.39M | 79.84M | 77.36M | 58.84M | 43.08M | -310.56M | -327.79M | -331.38M | -333.81M | 3.12M |
Shares Outstanding (Basic) | 161.72M | 160.97M | 159.9M | 159.71M | 159.01M | 157.7M | 156.01M | 155.89M | 155.37M | 154.45M | 153.34M | 180.48M | 153.3M | 184.27M | 163.29M | 162.74M | 161.95M | 160.97M |
Shares Outstanding (Diluted) | 161.72M | 160.97M | 160.42M | 160.23M | 159.01M | 157.7M | 156.01M | 186.89M | 155.37M | 186.68M | 185.19M | 184.47M | 184.88M | 189.54M | 165.63M | 165.24M | 163.5M | 162.35M |
EPS (Basic) | -0.04 | -0.2 | 0.01 | -0.02 | 0.06 | -6.78 | -6.45 | -6.12 | -5.94 | 1.14 | 1.05 | 0.98 | 1.04 | 3.22 | 3.26 | 3.28 | 3.16 | 0.90 |
EPS (Diluted) | -0.05 | -0.2 | 0.01 | -0.02 | 0.04 | -6.79 | -6.51 | -6.25 | -6.06 | 0.99 | 0.94 | 0.93 | 1.00 | 3.18 | 3.23 | 3.25 | 3.12 | 0.89 |
EBITDA | 80.02M | 60.23M | 100.24M | 105.74M | 120.72M | -980.25M | -924.87M | -890.03M | -860.51M | 269.95M | 261.44M | 241.87M | 237.95M | 244.1M | 233.33M | 231.21M | 208.39M | 179.05M |
EBIT | 78.08M | 58.25M | 98.23M | 103.7M | 118.68M | -982.05M | -926.84M | -890.38M | -861.12M | 268.74M | 260.02M | 238.98M | 235.04M | 241.25M | 230.57M | 229.46M | 205.24M | 175.71M |
Depreciation & Amortization | 1.94M | 1.98M | 2.01M | 2.04M | 2.04M | 1.8M | 1.57M | 1.4M | 1.26M | 1.35M | 1.42M | 1.44M | 1.43M | 1.47M | 1.52M | 1.58M | 3.05M | 3.29M |